Gianna Mariotti
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
Journal: Current oncology (Toronto, Ont.)
Published: June 25, 2023
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers' Performance.
Journal: Current issues in molecular biology
Published: June 14, 2023
Intermittent Versus Continuous Androgen Deprivation Therapy for Biochemical Progression After Primary Therapy in Hormone-Sensitive Nonmetastatic Prostate Cancer: Comparative Analysis in Terms of CRPC-M0 Progression.
Journal: Clinical genitourinary cancer
Published: May 04, 2023
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis.
Journal: Minerva urology and nephrology
Published: April 17, 2023
DDR genes analysis and PARP-inhibitors therapy as tailored management in metastatic prostate cancer: achieved answers, open questions and future perspectives.
Journal: Minerva urology and nephrology
Published: January 11, 2023
How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients.
Journal: International journal of molecular sciences
Published: December 02, 2022
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: November 04, 2022
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review.
Journal: International journal of molecular sciences
Published: August 17, 2022
Quantitative analysis of urinary incontinence after prostatectomy: lack of standardization in trials.
Journal: Minerva urology and nephrology
Published: May 24, 2022
Comment on: "Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis".
Journal: Minerva urology and nephrology
Published: May 24, 2022
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review.
Journal: Asian journal of urology
Published: May 08, 2022
Regenerative Medicine-Based Treatment of Stress Urinary Incontinence with Mesenchymal Stem Cells: A Systematic Review and Meta-analysis.
Journal: Current stem cell research & therapy
Published: February 20, 2022
Last Updated: 09/26/2026